Our Vision: A World Free of Pain

Grünenthal is a global leader in pain management.

Grünenthal Pharma Ltd., Ireland

Grünenthal Pharma Ltd., Ireland, a wholly owned subsidiary of Grünenthal GmbH, was established in 2005. With headquarters in Dublin, the company distributes and markets pain and anti-infective products under an exclusive distribution agreement with Grünenthal GmbH to GPs, hospital doctors, pharmacists, and nurses.

Improving pain management in UK & Ireland

CHANGE PAIN® is committed to improving pain management by providing healthcare professionals and patients with practical tools, resources, and educational content. Explore the latest insights and solutions to help manage pain effectively.

Visit the Change Pain UK website

Grünenthal Report 2025/26

Grünenthal is driven by a clear and ambitious vision: a World Free of Pain. In 2025, we made significant progress in advancing innovative medicines for patients living with pain worldwide. The Grünenthal Report is a key way we share updates on our collective projects, priorities, and progress. It provides an overview of our continued efforts to move closer to our vision.

The full Grünenthal Report is available here.

Responsibility Report 2024

As a recognised leader in environmental, social, and governance (ESG) matters, we proactively pursue best-in-class corporate sustainability practices. This report reflects the accomplishments of our teams worldwide around our focus areas of Patient People and Planet. Discover how our shared commitment is shaping long-term value.

Responsibility Report

Career

Be part of a dynamic, supportive team where every voice matters, and growth is encouraged through collaboration and respect. Discover how you can contribute to our mission of creating value for our customers, patients, community, and fellow team members.

View our current listings